SCHEMBL7344010

SCHEMBL7344010

CC(NC1Cc2cccc3ncn(c23)C1)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.65
DRD3 P35462 2/20 0.65
HTR1A P08908 2/20 0.47
GAA P10253 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GRM7 Q14831 2/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
LCK P06239 2/20 0.34
POLB P06746 2/20 0.33
ATM Q13315 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
GALR3 O60755 1/20 0.33
NR2F2 P24468 1/20 0.33
ALDH1A1 P00352 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6483129 0.79 DRD2 (1.00) DRD2DRD3HTR1A
SCHEMBL6356040 0.74 DRD2 (0.70) DRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL10446693 0.71 GAA (0.62) GAAL3MBTL1GRM7KMT2AMEN1
SCHEMBL7376178 0.69 DRD2 (0.62) DRD2DRD3HTR1A
SCHEMBL7343813 0.69 DRD2 (1.00) DRD2DRD3HTR1A
SCHEMBL3222580 0.69 DRD2 (1.00) DRD2DRD3HTR1A
SCHEMBL17530032 0.67 GAA (0.60) DRD2DRD3GAAL3MBTL1GRM7
SCHEMBL7336815 0.67 GAA (0.60) DRD2DRD3GAAL3MBTL1GRM7
SCHEMBL17530027 0.67 GAA (0.60) DRD2DRD3GAAL3MBTL1GRM7
SCHEMBL27818229 0.64 GAA (0.85) DRD3HTR1AGAAL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed